How effective LIMS software design can leverage evolving technologies to reduce risk and improve ROI. As the commercial LIMS marketplace evolves and matures, it continually faces the challenge of technology change

Australian venture capitalists invested more than $1 million per week in Australian biotechnology in the past financial year, an increase on the previous year and a recovery to the historic level of two years ago. As in the past, a large portion of the investment was made by a small number of investors, and was received by a small number of investees. [ + ]

What's New Magazines and Science Industry Australia Inc (SIA) invite entries to the Laboratory of the Year competition. All new or renovated laboratories completed and occupied between 1 January 2002 and 31 December 2004 are eligible to enter

GeoVOC represents a new approach to near-surface geochemical petroleum prospecting. Developed in conjunction with petroleum prospecting companies, GeoVOC uses SIFT-MS to reduce sample analysis time from up to thirty minutes to less than thirty seconds

When Francis Crick and James Watson deciphered the structure of DNA in 1953, x-ray crystallography became famous. X-ray crystallography has long since become the workhorse for structural studies of big biological molecules

With Biotechnology Innovation Fund and R&D Start grants rolled into the new Commercial Ready, the Australian biotech sector may face a post-BIF bust, writes Michael Vitale. [ + ]

At a recent conference in Sydney, biotechs and big pharma came together to explore how they should work together. Renate Krelle was there. [ + ]

The Science Industry Action Agenda is a joint initiative of Science Industry Australia Inc. (SIA) and the Commonwealth government, aimed at maximising the future growth and development of the science industry in Australia

A new technique for examining DNA is giving scientists a more detailed picture of which genes have the propensity for activation, offering a new tool for understanding how genes function and possibly for diagnosing disease

Dr John Raff tells Graeme O'Neill why Australia's agbiotech industry is struggling. [ + ]

One of the leading lights of international stem cell research will be in Australia next week, as a de facto ambassador for Wales as well as to discuss his research. [ + ]

Researchers from the University of Cambridge have made a breakthrough by using supercritical carbon dioxide (scCO2) as a reaction medium for the preparation of molecules of interest to the pharmaceutical industry

Preheating of the mobile phase has been shown to be an important parameter in attaining maximum performance in high temperature liquid chromatography (HTLC)

Clandestine drug laboratories present hazards and dangers to the community in all areas across Australia, including urban and rural centres

An Australian Law Reform Commission (ALRC) inquiry has found widespread anxiety and uncertainty about whether genetic patents will stifle research and development in the billion-dollar biotech industry